The GLP-1 analogue liraglutide improves first-phase insulin secretion and maximal beta-cell secretory capacity over 14 weeks of therapy in subjects with Type 2 diabetese

S Madsbad, T Vilsboell, Brock B., H Perrild, Hans Henrik Lervang, K Kolendorf, T Krarup, Ole Schmitz, M Zdrakovic, T Le-Thi

Research output: Contribution to journalConference abstract in journalResearch

Original languageEnglish
JournalDiabetic Medicine
Volume24
Pages (from-to)4
Number of pages1
ISSN0742-3071
Publication statusPublished - 2007
Externally publishedYes
EventThe GLP-1 analogue liraglutide improves first-phase insulin secretion and maximal beta-cell secretory capacity over 14 weeks of therapy in subjects with Type 2 diabetese -
Duration: 17 Dec 201017 Dec 2010

Conference

ConferenceThe GLP-1 analogue liraglutide improves first-phase insulin secretion and maximal beta-cell secretory capacity over 14 weeks of therapy in subjects with Type 2 diabetese
Period17/12/201017/12/2010

Cite this